Expression of CD10 and CD56 in Benign and Malignant Thyroid Lesions

Expression of CD10 and CD56 in Benign and Malignant Thyroid Lesions

The Part Immunohistochemical Markers (CK19 AND CD56) Play in Distinguishing Papillary Thyroid Carcinoma from Other Pathological Imitators

The diagnostic role of CK19 and CD73 immunohistochemistry in the diagnosis of papillary thyroid carcinoma

PDL1 Immunohistochemical Expression in Thyroid Neoplasms: A Possible Therapeutic Target

IMMUNOHISTOCHEMISTRY IN THE DIFFE‌RENTIAL DIAGNOSIS OF SOLITARY THYROID NODULE.

Value of cluster of differentiation 56, Hector Battifora mesothelial-1, and cytokeratin 19 expression in predicting the risk of papillary thyroid carcinoma occurrence in Hashimot

NtrkA Immunohistochemical Expression in Papillary Thyroid Carcinoma: A Clinicopathological Study

Aberrant Expression of CD56 in Hematologic Malignancies

Significance of TROP-2 and P63 Expression in Diagnosis of Papillary Thyroid Lesions: An immunohistopathological Study